|4Nov 25, 4:07 PM ET

Belle Gerald P. 4

4 · Myrexis, Inc. · Filed Nov 25, 2011

Insider Transaction Report

Form 4
Period: 2011-11-22
Transactions
  • Purchase

    Common Stock

    2011-11-23$2.48/sh+6,100$15,09840,600 total
  • Purchase

    Common Stock

    2011-11-22$2.48/sh+34,200$84,64534,500 total
Footnotes (4)
  • [F1]The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
  • [F2]Includes 300 shares acquired on June 30, 2009 in a pro rata distribution by Myriad Genetics, Inc. ("Myriad Genetics") of all of its shares of the Issuer's common stock in connection with the spin-off of the Issuer by Myriad Genetics.
  • [F3]The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
  • [F4]The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.

Documents

1 file
  • 4
    c25239_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION